Clinical Study
Relevance of Serum Leptin and Leptin-Receptor Concentrations in Critically Ill Patients
Table 2
Correlation analysis.
| | Leptin | Leptin-receptor | | | | | |
| Inflammation | | | | | Procalcitonin | 0.179 | .043 | 0.252 | .004 | Interleukin-10 | 0.190 | .049 | — | n.s. |
| Liver synthesis capacity | | | | | Protein concentration | 0.342 | .001 | — | n.s. | Albumin concentration | 0.295 | .001 | — | n.s. | Pseudocholinesterase | 0.281 | .001 | 0.217 | .012 | Prothrombin time (%) | 0.266 | .002 | — | n.s. | Antithrombin III | 0.234 | .012 | 0.22 | .017 |
| Cholestasis | | | | | GT | — | n.s. | 0.204 | .017 | AP | — | n.s. | 0.345 | .001 | Bilirubin (total) | — | n.s. | 0.298 | .001 | Bilirubin (conjugated) | — | n.s. | 0.373 | .001 |
| Glucose metabolism | | | | | Insulin | 0.430 | .001 | 0.294 | .001 | C-peptide | 0.285 | .001 | — | n.s. |
| Lipid metabolism | | | | | Cholesterol | 0.216 | .013 | — | n.s. | HDL cholesterol | 0.269 | .003 | — | n.s. | LDL cholesterol | 0.270 | .003 | — | n.s. |
| Adipocytokines | | | | | Adiponectin | 0.223 | .015 | 0.548 | .001 | Leptin | — | — | 0.587 | .001 |
|
|
GT: gamma-glutamyltranspeptidase; AP: alkaline phosphatase; HDL: high-density lipoprotein; LDL: low-density lipoprotein.
|